Matches in Wikidata for { <http://www.wikidata.org/entity/Q74276279> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q74276279 description "clinical trial" @default.
- Q74276279 description "ensayu clínicu" @default.
- Q74276279 description "klinisch onderzoek" @default.
- Q74276279 description "клінічне випробування" @default.
- Q74276279 description "կլինիկական փորձարկում" @default.
- Q74276279 name "Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome" @default.
- Q74276279 name "Liposomal Cytarabine and Daunorubicin" @default.
- Q74276279 type Item @default.
- Q74276279 label "Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome" @default.
- Q74276279 label "Liposomal Cytarabine and Daunorubicin" @default.
- Q74276279 prefLabel "Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome" @default.
- Q74276279 prefLabel "Liposomal Cytarabine and Daunorubicin" @default.
- Q74276279 P1050 Q74276279-14D681CE-CD5A-4C17-BB0D-CB23A9D89E86 @default.
- Q74276279 P1050 Q74276279-49A03084-6C44-4F42-893B-75364A944E8D @default.
- Q74276279 P1132 Q74276279-B232AC4E-891D-401C-B8CA-4D91E9C83CE5 @default.
- Q74276279 P1476 Q74276279-34391AAA-FE05-4A0B-BD93-ECF492B33653 @default.
- Q74276279 P17 Q74276279-D18EED20-4184-4B16-BE70-F3836F975254 @default.
- Q74276279 P2899 Q74276279-8D98BC6A-5392-4B91-BAC4-FE58F4B0800E @default.
- Q74276279 P3098 Q74276279-4A0CB621-8ADF-41C9-B779-CCE33BBA0B8E @default.
- Q74276279 P31 Q74276279-074C5495-68B7-4A28-9001-7D99E45FE007 @default.
- Q74276279 P4844 Q74276279-7662FD60-E264-4D76-8672-1C76AF29A348 @default.
- Q74276279 P580 Q74276279-34661F9D-04E8-405B-904D-A3EE5FF53DF9 @default.
- Q74276279 P582 Q74276279-FB02C3D1-72BC-4E4B-93AF-823956A7AC28 @default.
- Q74276279 P6099 Q74276279-39C3F146-5595-4AAD-A02A-05559FC4ADFD @default.
- Q74276279 P6099 Q74276279-45D57B4D-84D9-4FDB-AD55-6C9CDD1076FB @default.
- Q74276279 P8363 Q74276279-606269CE-83DE-4E7B-9FDD-38B93DEEDA98 @default.
- Q74276279 P1050 Q179630 @default.
- Q74276279 P1050 Q29496 @default.
- Q74276279 P1132 "+52" @default.
- Q74276279 P1476 "A Phase I/II Study of Liposomal Cytarabine and Daunorubicin (CPX-351) in Combination With Quizartinib in Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)" @default.
- Q74276279 P17 Q30 @default.
- Q74276279 P2899 "+18" @default.
- Q74276279 P3098 "NCT04128748" @default.
- Q74276279 P31 Q30612 @default.
- Q74276279 P4844 Q180983 @default.
- Q74276279 P580 "2020-02-28T00:00:00Z" @default.
- Q74276279 P582 "2021-12-31T00:00:00Z" @default.
- Q74276279 P6099 Q42824440 @default.
- Q74276279 P6099 Q5452194 @default.
- Q74276279 P8363 Q78089383 @default.